Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series
Valentino Bezzerri(Azienda Ospedaliera Universitaria Integrata Verona), Marco Cipolli(Azienda Ospedaliera Universitaria Integrata Verona)
Cited by 1
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis
|Orphanet Journal of Rare Diseases|2022|51
Traits, trends and hits of orphan drug designations in cystic fibrosis
|Journal of Cystic Fibrosis|2023|6